A role for p53 in the frequency and mechanism of mutation

Mutation Research - Reviews in Mutation Research

Volumn 511, Issue 1, 2002, Pages 45-62

  Morris, Suzanne M ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Loss of function; Mutant p53; p53; p53 knockout

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; MUTANT PROTEIN; PROTEIN P53; THYMIDINE KINASE;

CARCINOGENESIS; CHROMOSOME MUTATION; GENE LOCUS; GENE MUTATION; GENETIC RECOMBINATION; GENOME; HETEROZYGOSITY LOSS; HUMAN; LYMPHOBLASTOID CELL; MOLECULAR DYNAMICS; MUTAGENESIS; MUTATION RATE; NONHUMAN; NULL ALLELE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REPORTER GENE; REVIEW; SPONTANEOUS MUTATION; TRANSGENIC MOUSE; VIRUS;

MUS MUSCULUS;

EID: 0036127530     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(01)00075-8     Document Type: Article

References (149)

1. Cancer: p53, guardian of the genome
2. Tp53 tumour suppressor gene: Clues to molecular carcinogenesis and cancer therapy
3. Covalent and noncovalent modifiers of the p53 protein
4. How phosphorylation regulates the activity of p53
5. p53 phosphorylation: Biochemical and functional consequences
6. The p53 pathway and cancer therapy
7. New developments in the multi-site phosphorylation and integration of stress signaling at p53
8. Maintenance of genomic integrity by p53: Complementary roles for activated and non-activated p53
9. The p53 pathway
10. Regulation of p53 in response to DNA damage
11. p53 regulation by translational modification and nuclear retention in response to diverse stresses
12. Post-translational modifications and activation of p53 by genotoxic stresses
13. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 protein
14. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
15. SUMO-1 modification activates the transcriptional response of p53
16. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
17. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualization tools
18. Evolutionary conservation and somatic mutation hotspots maps of p53: Correlation with p53 protein structural and functional features
19. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
20. p53 mutational spectra and the role of methylated CpG sequences
21. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
22. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
23. p53 tumor-suppressor gene: Clues to molecular carcinogenesis
24. Dissociation of the recombination control and the sequence-specific transactivation function of p53
25. The dual role model for p53 in maintaining genomic integrity
26. Participation of p53 protein in the cellular response to DNA damage
27. WAF1, a potential mediator of p53 tumor suppression
28. +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa
29. p53 regulates a G2 checkpoint through cyclin B1
30. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
31. Inhibition of RNA polymerase II as a trigger for the p53 response
32. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced glucocorticoids and multiple chemotherapeutic drugs
33. Immediate up-regulation of bax expression by p53 but not by TGFβ1: A paradigm for distinct apoptotic pathways
34. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis
35. Negative regulation of bcl-2 expression by p53 in hematopoietic cells
36. The mitochondrial permeability transition pore and its role in cell death
37. Death signal-induced localization of p53 protein to mitochondria: A potential role in apoptotic signaling
38. Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function
39. Inhibition of p53 transcriptional activity by bcl-2 requires its membrane-anchoring domain
40. Inhibitory effect of bcl-2 on p53-mediated transactivation following genotoxic stress
41. Roles for p53 in growth arrest and apoptosis: Putting on the brakes after genotoxic stress
42. Regulation of p53 downstream genes
43. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery
44. 6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents
45. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair
46. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance
47. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts
48. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage
49. Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation
50. Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair
51. p53 modulation of TFIIH-associated nucleotide excision repair activity
52. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer
53. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation
54. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus
55. p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding
56. Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint
57. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein
58. Inactivation of p53 results in high rates of homologous recombination
59. Interaction of p53 with the human RAD51 protein
60. Specific mismatch recognition in heteroduplex intermediates suggests a role in fidelity control of homologous recombination
61. p53 protein exhibits 3′-5′ exonuclease activity
62. Different regulation of the p53 core domain activities 3′-5′ exonuclease and sequence-specific DNA binding
63. A novel role for the bcl-2 protein family: Specific suppression of the RAD51 recombination pathway
64. The contribution of homologous recombination in preserving genome integrity in mammalian cells
65. The interaction between p53 and DNA topoisomerase-I is regulated differently in cells with wild-type and mutant p53
66. Wild-type and mutant forms of p53 activate human topoisomersase I: A possible mechanism for gain of function in mutants
67. Poly ADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation
68. p53 dependence of topoisomerase I recruitment in vivo
69. Inhibition of DNA topoisomerase IIα gene expression by the p53 tumor suppressor
70. Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase in human hepatocellular carcinoma
71. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIα by enhancing the rate of ATP hydrolysis
72. Human topoisomerase IIα, and IIβ interact with the C-terminal region of p53
73. The p53 protein is an unusually shaped tetramer that binds directly to DNA
74. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation
75. Tumor suppressor p53: Analysis of wild-type and mutant p53 complexes
76. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of mdm2 protein and retention of a p53 dependent G1 arrest after irradiation
77. A comparison of the biological activities of wild-type and mutant p53
78. Structure, function and regulation of p63 and p73
79. p73 is a human p53-related protein that can induce apoptosis
80. Monoalleleically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
81. The potential tumor suppressor p73 differentially regulates cellular p53 target genes
82. Interaction of c-abl and p73α and their collaboration to induce apoptosis
83. The tyrosine kinase c-abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
84. p73 is regulated by tyrosine kinase c-abl in the apoptotic response to DNA damage
85. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53
86. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells
87. A common polymorphism acts as an intragenic modifier of mutant p53 behavior
88. p63, a p53 homologue at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities
89. The ARF/p53 pathway
90. Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
91. Regulation of p53 stability
92. The INK4A/ARF locus and its two gene products
93. p19ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of mdm2
94. Cooperative signals governing the ARF-mdm2 interaction and nuclear localization of the complex
95. Tumor surveillance via the ARF-p53 pathway
96. T-antigen is bound to host protein in SV40-transformed cells
97. The interaction between p53 and papillomaviruses
98. The role of E6-p53 interaction in the molecular pathogenesis of HPV
99. Adenovirus E1B 55K represses p53 activation in vitro
100. Adenovirus type 12 early region 1B 54K protein significantly extends the life span of normal mammalian cells in culture
101. Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor
102. DNA-sequence specificity of mutations at the thymidine kinase locus
103. Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation
104. The relative radiosensitivity of TK6 and WIL2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status
105. Altered p53 status correlated with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines
106. Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells
107. Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells
108. The tumor suppressor p53 modifies mutational processes in a human lymphoblasotid cell line
109. Requirement of wild-type p53 protein for maintenance of chromosomal integrity
110. Abrogation of p53 function by HPV16E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphpblastoid cells
111. Radiation-induced mutations at the autosomal thymidine kinase locus are not elevated in p53-null cells
112. Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism
113. Extensive loss of heterozygosity accounts for differential mutation rate on chromosome 17q in human lymphoblasts
114. +/- human lymphoblastoid cells
115. p53, mutations and apoptosis in genistein-exposed lymphoblastoid cells
116. +/- human lymphoblasotid cells
117. The influence of cellular apoptotic capacity on N-nitrosodimethylamine-induced loss of heterozygosity mutations in human cells
118. Rearrangement of the p53 gene in human osteogenic sarcomas
119. Decrease in the frequency of X-ray-induced mutation by wild-type p53 protein in human osteosarcoma cells
120. Reduced UV-induced mutations in human osteosarcoma cells stability expressing transfected wild-type p53 cDNA
121. p53 inactivation by HPV16E6 results in increased mutagenesis in human cells
122. Induction of p53 in mouse cells decreases mutagenesis by UV radiation
123. Spectra of X-ray-induced and spontaneous intragenic HPRT mutations in closely related human cells differentially expressing the p53 tumor suppressor gene
124. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
125. Tumor spectrum analysis in p53-mutant mice
126. Tumor-incidence, spectrum and ploidy in mice with a large deletion in the p53 gene
127. Insights into cancer from transgenic mouse models
128. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
129. p53 wild-type and p53 nullizygous Big Blue© transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain
130. -/- mice: A test of the guardian of the genome hypothesis in the Big Blue© transgenic mouse mutation detection systems
131. Increased mutation frequency and altered spectrum in one of four lymphomas derived from tumor prone p53/Big Blue© double transgenic mice
132. p53 deficiency does not affect the accumulation of point mutations in a transgene target
133. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination
134. Mitotic recombination produces the majority of recessive fiborblast variants in heterozygous mice
135. Chromosome instability contributes to loss of heterozygosity in mice lacking p53
136. Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning
137. High frequency genetic reversion mediated by a DNA duplication: The mouse pink-eyed unstable mutation
138. Reversion of the mouse pink-eyed unstable mutation induced by low doses of X-rays
139. Involvement of p53 in X-ray induced intrachromosomal recombination in mice
140. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene Xpa
141. Effect of heterozygous loss of p53 on benzo(a)pyrene induced mutations and tumors in DNA-repair-deficient Xpa mice
142. The role of excision repair and loss of p53 in mutagenesis and carcinogenesis
143. Absence of p53 permits propagation of mutant cells following genotoxic damage
144. Mutant p53 protein expression interferes with p53-independent apoptotic pathways
145. Suppression of apoptosis by bcl-2 and bcl-xl promotes susceptibility to mutagenesis
146. Suppression of apoptosis by overexpression of bcl-2 or bcl-xl promotes survival and mutagenesis after oxidative damage
147. +/- mouse model for detecting in vivo mutation in an endogenous, autosomal gene
148. High metastatic potential in mice inheriting a targeted p53 missense mutation